Myeloma Incidence and Mortality by Year, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 769 4.6 4.2-4.9 385 5.6 5.0-6.2 384 3.9 3.5-4.4 488 3.0 2.7-3.3 244 3.7 3.2-4.2 244 2.5 2.2-2.9
1977 757 4.5 4.2-4.9 372 5.5 4.9-6.1 385 3.9 3.5-4.3 499 3.0 2.7-3.2 247 3.6 3.1-4.1 252 2.5 2.2-2.9
1978 773 4.6 4.3-5.0 373 5.5 4.9-6.1 400 4.1 3.7-4.5 464 2.8 2.5-3.0 230 3.4 2.9-3.8 234 2.3 2.0-2.7
1979 831 4.9 4.6-5.3 394 5.8 5.2-6.4 437 4.4 4.0-4.8 505 3.0 2.8-3.3 235 3.5 3.0-4.0 270 2.7 2.4-3.1
1980 813 4.8 4.5-5.1 391 5.8 5.2-6.4 422 4.2 3.8-4.6 580 3.4 3.1-3.7 273 4.1 3.6-4.6 307 3.0 2.7-3.4
1981 914 5.4 5.0-5.7 428 6.2 5.6-6.9 486 4.8 4.4-5.3 542 3.2 2.9-3.5 255 3.9 3.4-4.4 287 2.8 2.5-3.1
1982 886 5.1 4.8-5.5 440 6.3 5.7-7.0 446 4.3 3.9-4.8 564 3.3 3.0-3.6 273 4.0 3.5-4.5 291 2.9 2.5-3.2
1983 866 5.1 4.7-5.4 446 6.6 6.0-7.3 420 4.1 3.7-4.5 562 3.3 3.0-3.6 265 3.9 3.5-4.5 297 2.9 2.5-3.2
1984 907 5.3 4.9-5.6 452 6.5 5.9-7.2 455 4.4 4.0-4.8 608 3.5 3.2-3.8 283 4.1 3.6-4.6 325 3.1 2.8-3.5
1985 924 5.3 5.0-5.7 460 6.6 6.0-7.2 464 4.5 4.1-4.9 607 3.4 3.2-3.7 315 4.6 4.1-5.1 292 2.7 2.4-3.1
1986 895 5.1 4.8-5.5 466 6.6 6.0-7.2 429 4.1 3.7-4.6 616 3.5 3.3-3.8 302 4.4 3.9-5.0 314 3.0 2.6-3.3
1987 924 5.3 4.9-5.6 468 6.7 6.1-7.3 456 4.3 3.9-4.7 607 3.5 3.2-3.7 316 4.6 4.1-5.2 291 2.8 2.4-3.1
1988 891 5.1 4.7-5.4 458 6.5 5.9-7.2 433 4.1 3.7-4.5 600 3.4 3.1-3.7 323 4.7 4.2-5.3 277 2.6 2.3-2.9
1989 984 5.6 5.3-6.0 449 6.4 5.8-7.0 535 5.1 4.7-5.6 578 3.3 3.0-3.5 281 4.0 3.6-4.5 297 2.7 2.4-3.1
1990 1,023 5.7 5.4-6.1 508 7.0 6.4-7.6 515 4.9 4.5-5.4 581 3.3 3.0-3.5 280 4.1 3.6-4.6 301 2.8 2.5-3.1
1991 978 5.4 5.1-5.8 463 6.4 5.8-7.0 515 4.8 4.4-5.3 614 3.4 3.2-3.7 291 4.1 3.6-4.6 323 3.0 2.7-3.4
1992 1,090 6.0 5.6-6.4 545 7.5 6.9-8.2 545 5.0 4.6-5.5 659 3.6 3.4-3.9 325 4.7 4.2-5.2 334 3.1 2.8-3.4
1993 1,037 5.7 5.4-6.1 497 6.7 6.1-7.4 540 5.0 4.6-5.5 706 3.9 3.6-4.2 341 4.7 4.2-5.3 365 3.3 3.0-3.7
1994 1,041 5.7 5.4-6.1 511 6.8 6.2-7.5 530 5.0 4.5-5.4 697 3.8 3.5-4.1 306 4.2 3.7-4.7 391 3.6 3.2-4.0
1995 1,078 5.9 5.5-6.2 539 7.3 6.7-7.9 539 5.0 4.6-5.5 707 3.8 3.6-4.1 353 4.8 4.3-5.3 354 3.2 2.9-3.6
1996 1,120 6.1 5.7-6.4 552 7.4 6.7-8.0 568 5.3 4.8-5.7 656 3.5 3.3-3.8 319 4.5 4.0-5.0 337 3.0 2.7-3.4
1997 1,106 5.9 5.6-6.3 533 6.9 6.3-7.5 573 5.3 4.9-5.7 654 3.5 3.2-3.8 324 4.4 3.9-4.9 330 3.0 2.7-3.3
1998 1,233 6.5 6.2-6.9 610 7.8 7.2-8.5 623 5.7 5.2-6.1 654 3.5 3.2-3.7 310 4.1 3.6-4.6 344 3.0 2.7-3.4
1999 1,248 6.5 6.2-6.9 596 7.6 7.0-8.2 652 5.8 5.4-6.3 677 3.5 3.3-3.8 328 4.3 3.8-4.8 349 3.0 2.7-3.4
2000 1,260 6.5 6.1-6.9 622 7.7 7.1-8.3 638 5.7 5.2-6.1 706 3.6 3.4-3.9 337 4.4 3.9-4.9 369 3.2 2.9-3.5
2001 1,280 6.5 6.2-6.9 677 8.3 7.7-9.0 603 5.3 4.9-5.7 648 3.3 3.1-3.6 328 4.1 3.7-4.6 320 2.7 2.4-3.1
2002 1,348 6.8 6.4-7.2 699 8.5 7.9-9.1 649 5.6 5.2-6.1 693 3.5 3.2-3.7 350 4.4 4.0-4.9 343 2.9 2.6-3.2
2003 1,338 6.7 6.3-7.0 693 8.3 7.7-9.0 645 5.6 5.1-6.0 645 3.2 3.0-3.5 335 4.1 3.7-4.6 310 2.6 2.3-2.9
2004 1,374 6.8 6.4-7.1 698 8.1 7.5-8.8 676 5.8 5.4-6.3 635 3.1 2.9-3.4 326 4.0 3.6-4.4 309 2.6 2.3-2.9
2005 1,425 6.9 6.6-7.3 721 8.3 7.7-8.9 704 6.0 5.5-6.4 650 3.2 2.9-3.4 321 3.8 3.4-4.2 329 2.7 2.4-3.0
2006 1,457 7.1 6.7-7.5 767 8.7 8.1-9.4 690 5.9 5.4-6.3 622 3.0 2.8-3.3 347 4.1 3.7-4.6 275 2.3 2.0-2.6
2007 1,475 7.1 6.7-7.5 774 8.8 8.1-9.4 701 5.9 5.5-6.4 681 3.3 3.0-3.5 345 4.0 3.6-4.4 336 2.7 2.5-3.1
2008 1,600 7.5 7.2-7.9 844 9.3 8.7-10.0 756 6.3 5.9-6.8 631 3.0 2.8-3.2 331 3.9 3.5-4.3 300 2.4 2.2-2.7
2009 1,720 8.0 7.7-8.4 914 9.9 9.3-10.6 806 6.6 6.1-7.1 647 3.0 2.8-3.2 351 3.9 3.5-4.4 296 2.3 2.1-2.6
2010 1,736 8.0 7.6-8.4 920 9.7 9.1-10.4 816 6.7 6.2-7.2 710 3.3 3.0-3.5 355 4.0 3.6-4.4 355 2.8 2.5-3.1
2011 1,832 8.3 7.9-8.7 997 10.4 9.7-11.0 835 6.8 6.3-7.2 649 2.9 2.7-3.1 321 3.5 3.1-3.9 328 2.5 2.3-2.8
2012 1,815 8.0 7.6-8.4 979 9.9 9.3-10.5 836 6.6 6.2-7.1 687 3.0 2.8-3.3 342 3.6 3.2-4.0 345 2.6 2.3-2.9
2013 1,930 8.4 8.0-8.8 1,053 10.5 9.8-11.1 877 6.8 6.4-7.3 662 2.9 2.6-3.1 358 3.7 3.3-4.1 304 2.3 2.0-2.6
2014 2,049 8.8 8.4-9.2 1,115 10.9 10.2-11.6 934 7.3 6.8-7.7 717 3.1 2.8-3.3 375 3.8 3.4-4.2 342 2.6 2.3-2.8
2015 1,953 8.3 7.9-8.7 1,046 10.1 9.5-10.8 907 6.9 6.5-7.4 735 3.1 2.9-3.3 401 4.0 3.6-4.4 334 2.4 2.2-2.7
2016 2,074 8.7 8.3-9.0 1,150 10.8 10.2-11.5 924 7.0 6.5-7.5 727 3.0 2.8-3.2 359 3.4 3.1-3.8 368 2.7 2.4-2.9
2017 2,056 8.4 8.1-8.8 1,113 10.3 9.7-11.0 943 6.9 6.5-7.4 712 2.9 2.7-3.1 369 3.5 3.2-3.9 343 2.4 2.1-2.7
2018 1,997 8.0 7.7-8.4 1,066 9.6 9.0-10.2 931 6.8 6.4-7.3 664 2.6 2.4-2.8 341 3.2 2.8-3.5 323 2.2 2.0-2.4
2019 2,066 8.3 7.9-8.6 1,133 10.1 9.5-10.7 933 6.8 6.4-7.3 670 2.6 2.4-2.8 376 3.4 3.1-3.8 294 1.9 1.7-2.2
2020 1,730 6.8 6.5-7.2 931 8.2 7.7-8.8 799 5.8 5.4-6.2 589 2.3 2.1-2.5 319 2.9 2.6-3.2 270 1.8 1.6-2.1

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.